- Home
- DV vs HCM Comparison
DV vs HCM Comparison
Compare DV & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DV
- HCM
- Stock Information
- Founded
- DV 2008
- HCM 2000
- Country
- DV United States
- HCM Hong Kong
- Employees
- DV N/A
- HCM N/A
- Industry
- DV Computer Software: Prepackaged Software
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- DV Technology
- HCM Health Care
- Exchange
- DV Nasdaq
- HCM Nasdaq
- Market Cap
- DV 2.2B
- HCM 2.5B
- IPO Year
- DV 2021
- HCM N/A
- Fundamental
- Price
- DV $13.73
- HCM $13.89
- Analyst Decision
- DV Buy
- HCM Hold
- Analyst Count
- DV 18
- HCM 1
- Target Price
- DV $19.08
- HCM $19.00
- AVG Volume (30 Days)
- DV 3.0M
- HCM 62.8K
- Earning Date
- DV 05-08-2025
- HCM 03-19-2025
- Dividend Yield
- DV N/A
- HCM N/A
- EPS Growth
- DV N/A
- HCM N/A
- EPS
- DV 0.29
- HCM 0.04
- Revenue
- DV $681,128,000.00
- HCM $630,201,000.00
- Revenue This Year
- DV $13.59
- HCM $14.86
- Revenue Next Year
- DV $11.88
- HCM $19.54
- P/E Ratio
- DV $46.99
- HCM $63.20
- Revenue Growth
- DV 15.30
- HCM N/A
- 52 Week Low
- DV $11.52
- HCM $11.51
- 52 Week High
- DV $23.11
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- DV 50.33
- HCM 50.07
- Support Level
- DV $13.09
- HCM $13.13
- Resistance Level
- DV $15.26
- HCM $13.66
- Average True Range (ATR)
- DV 0.43
- HCM 0.36
- MACD
- DV -0.06
- HCM 0.05
- Stochastic Oscillator
- DV 29.49
- HCM 81.25
About DV DoubleVerify Holdings Inc.
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.